References
- World Health Organization. Rabies vaccines: WHO position paper. Weekly Epidemiological Record 2010; 85:309 - 20
- World Health Organization. WHO expert consultation on rabies. Technical report series 982. WHO Geneva, 2013. Available from: http://apps.who.int/iris/bitstream/10665/85346/1/9789240690943_eng.pdf?ua=1
- World Health Organization. WHO expert consultation on rabies. Technical report series 931. WHO Geneva 2005. Available from: http://whqlibdoc.who.int/trs/WHO_TRS_931_eng.pdf
- Sudarshan MK, Mahendra BJ, Madhusudana SN, Ashwoath Narayana DH, Rahman A, Rao NS, X-Meslin F, Lobo D, Ravikumar K, Gangaboraiah. An epidemiological study of animal bites in India: results of a WHO sponsored national multi-centric rabies survey. J Commun Dis 2006; 38:32 - 9; PMID: 17370688
- Sudarshan MK, Ashwath Narayana DH. Ramesh Holla. An epidemiological appraisal of effectiveness of interchangeability of rabies vaccines for post-exposure prophylaxis in Bangalore city, India. APCRI Journal 2013; 14:6 - 9
- Sudarshan MK, Madhusudana SN, Mahendra BJ, Narayana DH, Giri MS, Muhamuda K, Ravish HS, Venkatesh GM. Boosting effect of purified chick embryo cell rabies vaccine using the intradermal route in persons previously immunized by the intramuscular route or vice versa. Natl Med J India 2006; 19:192 - 4; PMID: 17100105
- Ashwathnarayana DH, Madhusudana SN, Sampath G, Sathpathy DM, Mankeshwar R, Ravish HH, Ullas PT, Behra TR, Sudarshan MK, Gangaboraiah, et al. A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab). Vaccine 2009; 28:148 - 51; http://dx.doi.org/10.1016/j.vaccine.2009.09.090; PMID: 19818720
- Sampath G, Madhusudana SN, Sudarshan MK, Ashwathnarayana DH, Mahendra BJ, Ullas TP, Mohan K, Madhusudhan SK, Ravish HS. Immunogenicity and safety study of Indirab: a Vero cell based chromatographically purified human rabies vaccine. Vaccine 2010; 28:4086 - 90; http://dx.doi.org/10.1016/j.vaccine.2010.03.064; PMID: 20403351
- Sampath G, Reddy SV, Rao ML, Rao YU, Palaniappan C. An immunogenicity study of a newly introduced purified Vero cell rabies vaccine (Abhayrab) manufactured in India. Vaccine 2005; 23:897 - 900; http://dx.doi.org/10.1016/j.vaccine.2004.08.001; PMID: 15603890
- Plotkin SA, Koprowski H, Rupprecht CE. Rabies vaccines. In Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. 5th ed. Philadelphia, PA: Saunders; 2008:687-714.
- Finke S, Karger A, Freuling C, Müller T. Assessment of inactivated human rabies vaccines: biochemical characterization and genetic identification of virus strains. Vaccine 2012; 30:3603 - 9; http://dx.doi.org/10.1016/j.vaccine.2012.03.047; PMID: 22469862
- Nicholson KG. Cell culture vaccines for human use: General considerations. In: Meslin FX, Kaplan MM, Koprowski H. Laboratory techniques in rabies. 4th ed. Geneva: World Health Organization; 1996:271–9.
- Madhusudana SN, Sanjay TV, Mahendra BJ, Sudarshan MK, Narayana DH, Giri A, Muhamuda K, Ravi V, Vakil HB, Malerczyk C. Comparison of saftey and immunogenicity of purified chick embryo cell rabies vaccine (PCECV) and purified vero cell rabies vaccine (PVRV) using the Thai Red Cross intradermal regimen at a dose of 0.1 ML. Hum Vaccin 2006; 2:200 - 4 ; http://dx.doi.org/10.4161/hv.2.5.3197; PMID: 17035734
- Sudarshan MK, Narayana DH, Madhusudana SN, Holla R, Ashwin BY, Gangaboraiah B, Ravish HS. Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: results of a randomized, open label, active-controlled trial in healthy adult volunteers in India. Hum Vaccin Immunother 2012; 8:1077 - 81; http://dx.doi.org/10.4161/hv.20471; PMID: 22699446
- Sudarshan MK, Madhusudana SN, Mahendra BJ, Ashwath Narayana DH, Ananda Giri MS, Popova O, Vakil HB. Evaluation of a new five-injection, two-site,intradermal schedule for purified chick embryo cell rabies vaccine: A randomized, open-label, active-controlled trial in healthy adult volunteers in India. Curr Ther Res Clin Exp 2005; 66:323 - 34; http://dx.doi.org/10.1016/j.curtheres.2005.08.009; PMID: 24672132